This Article  • Full text  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Ophthalmol. 2007;125(7):994.

	Since this article does not have an abstract, we have provided the first 86 words of the full text and any section headings.

The local clinical use of a 30 per cent solution of sodium sulfacetimide was first reported by Dickson. Under the auspices of the Ross Foundation for the Prevention of Blindness, in a trial period of six months, of 11,953 cases of ocular injuries, there were only 7 instances of corneal ulcer, while before the use of this drug 350 cases of corneal ulcer occurred in a three year period. Thus the preventive value is obvious.

Reference: Mayer LL. Sodium sulfacetimide in ophthalmology. Arch Ophthalmol. 1948;39(2):232-235.